Figure 1. Structure of obatoclax and schematic of release of activated Bak (Bak*) from Bcl-2 following exposure to obatoclax and recruitment of Bax to form hetero-oligomers detectable by a conformation-specific antibody.
Figure 1

Structure of obatoclax and schematic of release of activated Bak (Bak*) from Bcl-2 following exposure to obatoclax and recruitment of Bax to form hetero-oligomers detectable by a conformation-specific antibody.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal